Dealing with the Isolation of Cancer Treatment

Video

Larry Whipple had to travel 1,500 miles from his hometown for a second opinion after he was diagnosed with advanced lung cancer, but through the course of his treatment he had to remain in isolation to avoid further illness.

After receiving a diagnosis of advanced lung cancer, Larry Whipple became his best own advocate by asking the right questions and seeking the most qualified experts — including finding a second opinion nearly 1,500 miles from his hometown. But as he soon found out the diagnosis, he realized his journey would be a difficult one, mostly due to his need to live in isolation to keep his immune system as healthy as possible.

Here, Whipple explains how his approach to isolation helped him get through the tough times, mainly by managing his expectations. “If you manage your expectations and you can manage them effectively,” Whipple says, “you can be a pretty happy and content person, because you’re not disappointed.”

Transcription:

The chemotherapy (severely weakens) your immune system. Once the chemo started, I literally was quarantined for about six months.

Seriously, I mean, I didn’t go out of the home. My wife and I didn’t do any socializing. We saw my son and daughter-in-law once in a while. They have four children, so I didn’t really want to be exposed in any way. The isolation was very difficult. The actual treatment was a cakewalk. It had absolutely zero effect. You can see my coiffure here: That’s by choice and genetics; it has nothing to do with chemo.

I’ve learned in life that happiness and contentment is all related to what your expectations are. So, if you manage your expectations and you can manage them effectively, you can be a pretty happy and content person, because you’re not disappointed.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.